Abstract:Background: Bladder cancer (BCa) is the 4th most common cancer diagnosed in men, with 82,290 new cases predicted in 2023. As BCa frequently occurs at an advanced patient age, its diagnosis may follow radiotherapy (RT) for the treatment of prostate cancer. Currently, data is limited regarding the influence of RT on the clinical course and genomic landscape of subsequent BCa, mainly due to a paucity of samples. From prior studies, pelvic radiation confers an increased risk of BCa, with resulting tumors that are largely genomically similar to non-RT tumors with the exception of an increase rate of genomic insertions. Our current study looks to expand on these findings by characterizing the genomes of the largest cohort of RT-associated bladder cancers to date. Methods: We identified BCa cases from patients with a prior history of pelvic radiation for prostate cancer, and tumor only targeted sequencing was performed using Foundation Medicine (FMI) on FFPE tissue (n=41). For control cases (CTRL), patients with no prior record of pelvic radiation and who had previously underwent standard of care FMI sequencing were included (n=41). Sequencing data were re-aligned to hg38 and mutation calling was performed on the newly aligned sequences. Results: CTRL and RT cohorts had similar distributions of patients based on race and smoking status. While cT stage was similar between the two cohorts, the CTRL cohort was biased toward higher cN and cM stages with no difference in overall survival (median OS: CTRL = 20m, RT = 23m), though the advanced stage of the CTRL cohort could mask a worse prognosis in the RT cohort. Latency specific analysis revealed short latency tumors (<10 years from RT) had a significantly shorter overall survival than long latency tumors (p<0.01, HR=5.59, CI=1.81-17.3), and a numerically, but not significantly, shorter survival than CTRL patients (p=0.17, HR=1.55, CI=0.82-2.94). Long latency tumor patients had a significantly longer overall survival than CTRL patients (p<0.01, HR = 0.22, CI=0.07-0.63). In line with prior studies, RT samples had increased numbers of insertions (p<0.01). In addition, we also detected an increase in SNVs in the RT samples (p<0.01). Of note, KDM6A alterations were enriched within the RT cohort (CTRL = 10/41, RT = 30/41, p<0.001), with series of splice site mutations exclusive to RT samples (p<0.001). Conclusion: Patients diagnosed with BCa within a short interval following pelvic radiation have a worse prognosis. Genomic analysis showed RT-associated tumors having an increased number of insertions, SNVs, and KDM6A splice site mutations compared to non-RT tumors. Overall, the spectrum of recurrent alterations within the cohorts were consistent with previous studies, with the exception of the KDM6A mutations. To our knowledge, this is the first report of a RT-associated alteration in a specific gene in bladder cancer and additional studies will be needed to validate and understand the consequences of this finding. Citation Format: N. Ari Wijetunga, Kathryn H. Gessner, Krishna Kanchi, Sara E. Wobker, David Corcoran, Matthew D. Galsky, Matthew I. Milowsky, William Y. Kim, Tracy L. Rose, Jeffrey S. Damrauer. Genomic characterization of radiotherapy-associated bladder cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 1123.

Long Term Exposure to Γ‑rays Induces Radioresistance and Enhances the Migration Ability of Bladder Cancer Cells

Bmi-1 Confers Adaptive Radioresistance to Kyse-150r Esophageal Carcinoma Cells

Down-regulation of autophagy-associated protein increased acquired radio-resistance bladder cancer cells sensitivity to taxol

EZH2 Targeting to Improve the Sensitivity of Acquired Radio-Resistance Bladder Cancer Cells

STAT3 Enhances Radiation-Induced Tumor Migration, Invasion and Stem-Like Properties of Bladder Cancer.

Abstract 1123: Genomic characterization of radiotherapy-associated bladder cancer

Optimization of BCG Therapy Targeting Neutrophil Extracellular Traps, Autophagy, and Mirnas in Bladder Cancer: Implications for Personalized Medicine

ATM Mediates DAB2IP-deficient Bladder Cancer Cell Resistance to Ionizing Radiation Through the P38mapk and NF-κB Signaling Pathway

Abstract 1110: Estrogen receptor β signaling induced radio-resistance in bladder cancer

Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation

EGFR/TKIs induce excessive apoptosis of bladder carcinoma cells by arresting cell cycle and promoting mitochondrial peroxidation damage

High-dose radiation-induced immunogenic cell death of bladder cancer cells leads to dendritic cell activation

Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.

The immune mediated role of extracellular HMGB1 in a heterotopic model of bladder cancer radioresistance

Hypofractionated Radiation Induced the Immunogenic Death of Bladder Cancer Cells Leading to the Immune Sensitization of Dendritic Cells

The ATM Inhibitor KU55933 Sensitizes Radioresistant Bladder Cancer Cells with DAB2IP Gene Defect

Enhanced Efficacy Of Azd3759 And Radiation On Brain Metastasis From Egfr Mutant Non-Small Cell Lung Cancer

YM155 Decreases Radiation-Induced Invasion and Reverses Epithelial–mesenchymal Transition by Targeting STAT3 in Glioblastoma

Radiation Engenders Converse Migration and Invasion in Colorectal Cancer Cells Through Opposite Modulation of ANXA2/AKT/GSK3β Pathway.

Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence

Upregulating DAB2IP Expression Via EGR-1 Inhibition, a New Approach for Overcoming Fractionated-Irradiation-induced Cross-Tolerance to Ionizing Radiation and Mitomycin C in Tumor Cells.